Completed PHASE2 INTERVENTIONAL 1-arm NCT00154778

Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer

An Open,Multi-Center,Phase II Clinical Trial tO Evaluate Efficacy and Safety oF TAXOL(PACLITAXEL),UFT,and LEUCOVORIN in Patients With Advanced Gastric Cancer

Sponsor: Mackay Memorial Hospital

Conditions Gastric Cancer

Interventions Taxol, UFT,Leucovorin

Updated 5 times since 2017 Last updated: Jul 30, 2007 Started: Mar 31, 2003 Completion: Jun 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00154778, this PHASE2 trial focuses on Gastric Cancer and remains completed. Sponsored by Mackay Memorial Hospital, it has been updated 5 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mackay Memorial Hospital
National Cheng-Kung University Hospital
National Health Research Institutes, Taiwan
National Taiwan University Hospital
Taipei Veterans General Hospital, Taiwan
Tri-Service General Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan